TECTONIC THERAPEUTIC, INC. (TECX) Debt Components
- 2023-03-31: Long-term DebtUSD $15.00M; Long-Term Debt, Maturity, Year OneUSD $1.88M; Long-Term Debt, Maturity, Year TwoUSD $7.50M; Long-Term Debt, Maturity, Year ThreeUSD (m).
- 2022-12-31: Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
- 2022-12-31: Long-term DebtUSD $15.00M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $1.88M; Long-Term Debt, Maturity, Year ThreeUSD $7.50M.
- 2022-09-30: Long-term DebtUSD $15.00M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD $1.88M; Long-Term Debt, Maturity, Year ThreeUSD $7.50M.
TECTONIC THERAPEUTIC, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Line of Credit Facility, Capacity Available for Trade Purchases USD | Long-term Debt, Gross USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $15.00M | $1.88M | $7.50M | (m) | $5.62M | (m) | $0.00 | (m) | (m) | $16.35M |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $16.35M |
| 2022-12-31 | $15.00M | $0.00 | $1.88M | $7.50M | $5.62M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $15.00M | (m) | $1.88M | $7.50M | $5.62M | (m) | (m) | (m) | (m) | $16.35M |
| 2022-06-30 | $15.00M | (m) | $1.88M | $7.50M | $5.62M | (m) | (m) | (m) | (m) | $16.35M |
| 2022-03-31 | $15.00M | (m) | $1.88M | $7.50M | $5.62M | (m) | (m) | (m) | (m) | $16.35M |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $16.35M |
| 2021-12-31 | $15.00M | (m) | (m) | $1.88M | $7.50M | $5.62M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) |
| 2017-06-23 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |